By Navy Region Europe, Africa, Central Public Affairs
Medical personnel assigned to the Navy’s newest shore installation, Naval Support Facility (NSF) Redzikowo, Poland, began the process of inoculating the base’s Sailors and civilians with the Moderna COVID-19 vaccine on Feb. 13, 2021.
Medical, emergency services, and public safety personnel assigned to Redzikowo and tenant command Aegis Ashore Missile Defense System (AAMDS) Poland were among the first to be inoculated.
The Moderna vaccine is currently being offered to Department of Defense (DoD) personnel on a voluntary basis. It was one of two COVID-19 vaccines approved under an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration in December 2020.
“The vaccine is an important tool in protecting our personnel against COVID-19, and the health and safety of our Sailors and civilians is our top priority,” said Capt. Sam Davis, NSF Redzikowo’s commanding officer.
As NSF Redzikowo receives further doses of the vaccine, installation leadership will move through the prescribed DoD distribution tiers to offer the vaccine to additional personnel. At this time, there is no estimated timeline for the receipt of additional vaccines.
All personnel will continue to practice preventive measures against COVID-19, including wearing masks, maintaining physical distancing, washing hands, and restriction of movement, in order to protect their safety.
NSF Redzikowo’s operations enable the responsiveness of U.S. and Allied forces in support of the mission of Navy Region Europe, Africa, Central (EURAFCENT) to provide services to the fleet, fighter, and family throughout the European, African, and Central Command theaters of operation.